Intensity Therapeutics
INTS
13 hedge funds and large institutions have $836K invested in Intensity Therapeutics in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 25 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
5.37% more ownership
Funds ownership: 0.27% → 5.64% (+5.4%)
49% less capital invested
Capital invested by funds: $1.63M → $836K (-$789K)
63% less funds holding
Funds holding: 35 → 13 (-22)
80% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCNMGF
Nano-Cap New Millennium Growth Fund
Staten Island,
New York
|
+$204K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.1K |
| 3 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$33.3K |
| 4 |
SL
Sentinus LLC
Oak Brook,
Illinois
|
+$28.2K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Corient Private Wealth
Miami,
Florida
|
-$82K |
| 2 |
LA
Legacy Advisors
Plymouth Meeting,
Pennsylvania
|
-$62.9K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$58.7K |
| 4 |
State Street
Boston,
Massachusetts
|
-$55.9K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$53.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EL
26
EWA LLC
Pittsbugh,
Pennsylvania
| – | -$17K | -1,654 | Closed |
|
|
TSS
27
Two Sigma Securities
New York
| – | -$14.3K | -1,393 | Closed |
|
|
OCPWS
28
One Charles Private Wealth Services
Hingham,
Massachusetts
| – | -$13K | -1,272 | Closed |
|
29
William Blair & Company
Chicago,
Illinois
| – | -$12.4K | -1,208 | Closed |
|
|
QFW
30
QTR Family Wealth
Lake Mary,
Florida
| – | -$6.52K | -697 | Closed |
|
|
MG
31
Marex Group
London,
| – | -$6.15K | -600 | Closed |
|
|
SCA
32
Sassicaia Capital Advisers
Jericho,
New York
| – | -$6.15K | -600 | Closed |
|
|
TC
33
T3 Companies
New York
| – | -$5.58K | -544 | Closed |
|
34
Vontobel Holding
Zurich,
Switzerland
| – | -$4.86K | -480 | Closed |
|
|
BPA
35
Beacon Pointe Advisors
Newport Beach,
California
| – | -$4.18K | -408 | Closed |
|
|
WIA
36
World Investment Advisors
Santa Barbara,
California
| – | -$4.1K | -400 | Closed |
|
37
Bank of America
Charlotte,
North Carolina
| – | -$240 | -23 | Closed |
|
38
Citigroup
New York
| – | -$36 | -4 | Closed |
|
INTS Hedge Fund Activity: Q1 2026 in Review
13 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Intensity Therapeutics (INTS) for Q1 2026, worth a combined $836K — down 49% from $1.63M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of INTS and 5 opened new positions — a net loss of 20 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Nano-Cap New Millennium Growth Fund, opening a new position worth an estimated $204K. The largest seller was Corient Private Wealth, exiting entirely with an estimated $82K sold.
- 13 institutional investors held Intensity Therapeutics (INTS) as of Q1 2026, down from 35 in Q4 2025.
- Funds reported $836K of Intensity Therapeutics stock for Q1 2026, down 49% quarter-over-quarter.
- 5 funds opened new Intensity Therapeutics positions in Q1 2026 and 25 closed out, a net change of -20 holders.
- The largest Intensity Therapeutics buyer in Q1 2026 was Nano-Cap New Millennium Growth Fund, an estimated $204K added.
- The largest Intensity Therapeutics seller in Q1 2026 was Corient Private Wealth, an estimated $82K sold.
Based on aggregated 13F filings for Q1 2026.